Concepedia

Author

David Tsang

The Christie NHS Foundation Trust

Also Known As

Abby Cyriac, David J. Tsang, David Tsang

13

Publications

2.4K

Citations

8

H-Index

12

Concepts

All Affiliations

The Christie NHS Foundation TrustUniversity College LondonVelindre Cancer CentreMRC Clinical Trials Unit at UCLRoyal Marsden NHS Foundation Trust
DT

About

David Tsang is an author at The Christie NHS Foundation Trust specializing in clinical trials, gynecology oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

61

2

Medicine

1

1

61

3

Pharmacology

1

1

61

4

Radiation Medicine

1

1

61

5

Cancer Therapeutics

1

1

61

David Tsang

×

7

Publications

2.4K

Citations

7

H-Index

YearCitations

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Nicholas D. James, Matthew R. Sydes, Noel W. Clarke,

The Lancet

2015

1.9K

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

John Bridgewater, S. Pugh, Tom Maishman,

The Lancet Oncology

2020

227

SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes: a randomized controlled trial

M. Yudi, David Clark, David Tsang,

Coronary Artery Disease

2020

74

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial

Malcolm D. Mason, Noel W. Clarke, Nicholas D. James,

Journal of Clinical Oncology

2017

61

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook,

The Lancet

2024

43

SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes [SMART-REHAB Trial]: a randomized controlled trial protocol

M. Yudi, David Clark, David Tsang,

BMC Cardiovascular Disorders

2016

41

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness

Beth Woods, E.G. Sideris, Matthew R. Sydes,

European Urology Oncology

2018

26

Page 1